KINETA
Kineta is a biotechnology company engaging in the discovery and development of antiviral therapies and immune-modulating drugs for the treatment of RNA viruses that include hepatitis C, influenza, West Nile virus, and the common cold. Kineta was founded in 2008 and is based in Seattle, Washington.
KINETA
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2008-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.kinetabio.com
Total Employee:
11+
Status:
Active
Contact:
(206)378-0400
Email Addresses:
[email protected]
Total Funding:
81.48 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Domain Not Resolving
Similar Organizations
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
Cheongbo Industrial Co. (CBI)
Cheongbo Industrial Co. (CBI) investment in Corporate Round - Kineta
SCHLAEPFER FAMILY FOUNDATION
SCHLAEPFER FAMILY FOUNDATION investment in Venture Round - Kineta
Wellcome Trust
Wellcome Trust investment in Grant - Kineta
SFC Capital
SFC Capital investment in Venture Round - Kineta
Keiretsu Forum
Keiretsu Forum investment in Venture Round - Kineta
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - Kineta
Keiretsu Forum Northwest
Keiretsu Forum Northwest investment in Venture Round - Kineta
Keiretsu Capital
Keiretsu Capital investment in Series B - Kineta
AngelMD
AngelMD investment in Funding Round - Kineta
RJ Jones
RJ Jones investment in Venture Round - Kineta
Newest Events participated
Participated in 15th annual Future in Review Conference
on 2017-10-10 as sponsor
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-28 | Kineta Announces Appointment of Thierry Guillaudeux, PhD to Chief Scientific Officer |
Official Site Inspections
http://www.kinetabio.com Semrush global rank: 5.59 M Semrush visits lastest month: 1.52 K
Unable to get host informations!!!
More informations about "Kineta"
About Us-FULL TEAM – Kineta Inc.
Kineta has assembled an experienced management team, a seasoned research and clinical team, an immuno-oncology focused scientific advisory board, and a leading intellectual property position to advance its pipeline of potential novel … See details»
Kineta - LinkedIn
Kineta is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives. See details»
Kineta - Overview, News & Similar companies | ZoomInfo.com
View Kineta (kinetabio.com) location in Washington, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more. See details»
Kineta - Crunchbase Company Profile & Funding
Kineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas. See details»
Kineta - 2025 Company Profile & Team - Tracxn
Jun 23, 2025 Kineta - Developing immune-modulating therapeutics and vaccine adjuvants for autoimmune and infectious diseases. Acquired by TuHURA Biosciences. Raised a total … See details»
Kineta Company Profile | Management and Employees List
Find contact information for Kineta. Learn about their Research & Development, Business Services market share, competitors, and Kineta's email format. See details»
Kineta Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Kineta has 5 employees at their 1 location. See insights on Kineta including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. See details»
Kineta, Inc. | Seattle, WA, USA Startup - Gust
Kineta: An emerging biotech company that fills a void in the biotech industry by advancing first in class immuno-therapies from discovery to proof of concept. See details»
Kineta Information - RocketReach
Kineta is a Biotechnology, Drug Discovery, and Autoimmune Diseases company located in Seattle, Washington with 41 employees. Find top employees, contact details and business … See details»
Controller – Kineta Inc. - kinetabio.com
Kineta is a great place to work where exciting science and committed people come together. Our team consists of pioneers in immunology and virology that have made leading discoveries in … See details»
Kineta Company Overview, Contact Details & Employees
Kineta specializes in Business Services, Research & Development with 11 employees Phone Number: +1 2063780400 Email Address: [email protected] Overview Employees Access 41 … See details»
Kinea Bio
Jun 10, 2025 Kinea Bio was founded in 2020 by highly-respected scientific leaders in the neuromuscular disease space with a history of bench-to-bedside innovations. See details»
Committee Composition – Kineta Inc. - kinetabio.com
Biodefense Innate Immune Antivirals Vaccine Adjuvants lhf-535 arenaviruses broad spectrum antiviral drugs lhf-535 Lassa Fever See details»
Kineta CEO and Key Executive Team - Craft.co
Kineta's Director & CEO is Shawn Iadonato. Other executives include Craig W. Philips, President; Eric Tarcha, EVP, Research & Development and 5 others. See the full leadership team at Craft. See details»
Kineta - Products, Competitors, Financials, Employees, …
About Kineta Kineta is a clinical stage biotechnology company that focuses on the development of immunotherapies. The company's main offerings include the development of treatments … See details»
Kineta Enters Research Collaboration and License Agreement
Dec 17, 2018 Kineta Immuno-Oncology to receive $15 million upfront and will be eligible to receive up to $505 million in potential research, development and sales milestone payments … See details»
Kineta Expands Board of Directors with Biotech Industry Leaders …
SEATTLE, June 28, 2023 — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer … See details»
Splash - TuHURA
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. See details»
Kim Drapkin – Kineta Inc. - kinetabio.com
Kim Drapkin Director Kim Drapkin has over 25 years of experience working with private and publicly traded biotechnology and pharmaceutical companies, including building and leading … See details»
Kineta Announces Formation of New Immuno-oncology Focused …
Apr 21, 2020 Kineta Announces Formation of New Immuno-oncology Focused Scientific Advisory Board Seattle, WA — (April 21, 2020) Kineta, Inc., a clinical stage biotechnology … See details»